Skip to main content
. 2020 Dec 15;42(4):570–577. doi: 10.1093/carcin/bgaa137

Table 1.

Concentrations of [D10]Phe metabolites in 6-h urine (nmol/6-h urine)

[D10]Phe metabolites
[D10]1,2-PheD [D10]PheT Total [D9]OHPhe
Non-smokers (1 μg dose, N = 57) Mean (range) 0.39 (ND ~1.61) 0.11 (0.02–0.25) 0.28 (0.05–1.55)
SD 0.40 0.06 0.23
CV (%) 102 52.0 80.8
Median (25th, 75th) 0.23 (0.12, 0.44) 0.11 (0.07, 0.14) 0.24 (0.15, 0.34)
Smokers (1 μg dose, N = 35) Mean (range) 0.36 (ND ~1.29) 0.14 (0.003–0.29) 0.18 a(ND ~0.68)
SD 0.33 0.07 0.14
CV (%) 90.2 55.2 77.5
Median (25th, 75th) 0.23 (0.14, 0.56) 0.14 (0.07, 0.17) 0.16 (0.07, 0.24)
Smokers (10 μg dose, N = 135) Mean (range) 6.55 a(ND ~28.63) 2.26 a(ND ~7.75) 1.13 a(ND ~6.41)
SD 4.37 1.67 0.75
CV (%) 66.7 73.9 66.7
Median (25th, 75th) 5.49 (3.29, 9.33) 1.82 (0.88, 3.38) 1.01 (0.65, 1.47)

aBolded values, P < 0.01 compared with non-smokers, Wilcoxon rank-sum test.

CV, coefficient of variation.